These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 17024658)

  • 1. Amplification strategies in MR imaging: activation and accumulation of sensing contrast agents (SCAs).
    Querol M; Bogdanov A
    J Magn Reson Imaging; 2006 Nov; 24(5):971-82. PubMed ID: 17024658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Visualization of the enzymatic activity in living systems using activated NMR contrast agents].
    Bogdanov AA; Querol M; Chen JW
    Biofizika; 2007; 52(3):389-400. PubMed ID: 17633527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pushing the sensitivity envelope of lanthanide-based magnetic resonance imaging (MRI) contrast agents for molecular imaging applications.
    Aime S; Castelli DD; Crich SG; Gianolio E; Terreno E
    Acc Chem Res; 2009 Jul; 42(7):822-31. PubMed ID: 19534516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemistry of paramagnetic and diamagnetic contrast agents for Magnetic Resonance Imaging and Spectroscopy pH responsive contrast agents.
    Pérez-Mayoral E; Negri V; Soler-Padrós J; Cerdán S; Ballesteros P
    Eur J Radiol; 2008 Sep; 67(3):453-8. PubMed ID: 18455343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved detection of gadolinium enhancement using magnetization transfer imaging.
    Elster AD; Mathews VP; King JC; Hamilton CA
    Neuroimaging Clin N Am; 1994 Feb; 4(1):185-92. PubMed ID: 8130949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrast agents: magnetic resonance.
    Burtea C; Laurent S; Vander Elst L; Muller RN
    Handb Exp Pharmacol; 2008; (185 Pt 1):135-65. PubMed ID: 18626802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular imaging with targeted contrast agents.
    Makowski MR; Wiethoff AJ; Jansen CH; Botnar RM
    Top Magn Reson Imaging; 2009 Aug; 20(4):247-59. PubMed ID: 20805735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basic principles of magnetic resonance contrast agents.
    Kirsch JE
    Top Magn Reson Imaging; 1991 Mar; 3(2):1-18. PubMed ID: 2025431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Environment-sensitive and enzyme-sensitive MR contrast agents.
    Querol M; Bogdanov A
    Handb Exp Pharmacol; 2008; (185 Pt 2):37-57. PubMed ID: 18626598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Gd3+-based magnetic resonance imaging contrast agent sensitive to beta-galactosidase activity utilizing a receptor-induced magnetization enhancement (RIME) phenomenon.
    Hanaoka K; Kikuchi K; Terai T; Komatsu T; Nagano T
    Chemistry; 2008; 14(3):987-95. PubMed ID: 17992679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic resonance chemical exchange saturation transfer imaging and nanotechnology.
    Winter PM
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2012; 4(4):389-98. PubMed ID: 22422650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A paramagnetic contrast agent with myeloperoxidase-sensing properties.
    Querol M; Chen JW; Bogdanov AA
    Org Biomol Chem; 2006 May; 4(10):1887-95. PubMed ID: 16688334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies for increasing the sensitivity of gadolinium based MRI contrast agents.
    Caravan P
    Chem Soc Rev; 2006 Jun; 35(6):512-23. PubMed ID: 16729145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic resonance imaging (MRI) contrast agents for tumor diagnosis.
    Cheng W; Ping Y; Zhang Y; Chuang KH; Liu Y
    J Healthc Eng; 2013; 4(1):23-45. PubMed ID: 23502248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo visualization of gene expression using magnetic resonance imaging.
    Louie AY; Hüber MM; Ahrens ET; Rothbächer U; Moats R; Jacobs RE; Fraser SE; Meade TJ
    Nat Biotechnol; 2000 Mar; 18(3):321-5. PubMed ID: 10700150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of lanthanide-grafted inorganic nanoparticles as effective contrast agents for cellular uptake imaging.
    Voisin P; Ribot EJ; Miraux S; Bouzier-Sore AK; Lahitte JF; Bouchaud V; Mornet S; Thiaudière E; Franconi JM; Raison L; Labrugère C; Delville MH
    Bioconjug Chem; 2007; 18(4):1053-63. PubMed ID: 17511491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triethylenetetramine penta- and hexa-acetamide ligands and their ytterbium complexes as paraCEST contrast agents for MRI.
    Burdinski D; Lub J; Pikkemaat JA; Moreno Jalón D; Martial S; Del Pozo Ochoa C
    Dalton Trans; 2008 Aug; (31):4138-51. PubMed ID: 18688432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MRI probes for sensing biologically relevant metal ions.
    Bonnet CS; Tóth E
    Future Med Chem; 2010 Mar; 2(3):367-84. PubMed ID: 21426172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights into the use of paramagnetic Gd(III) complexes in MR-molecular imaging investigations.
    Aime S; Cabella C; Colombatto S; Geninatti Crich S; Gianolio E; Maggioni F
    J Magn Reson Imaging; 2002 Oct; 16(4):394-406. PubMed ID: 12353255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osmotically shrunken LIPOCEST agents: an innovative class of magnetic resonance imaging contrast media based on chemical exchange saturation transfer.
    Terreno E; Delli Castelli D; Violante E; Sanders HM; Sommerdijk NA; Aime S
    Chemistry; 2009; 15(6):1440-8. PubMed ID: 19115311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.